Healthagen company logo

The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

healthagen.com

Stage

Acquired | Acquired

About Healthagen

Healthagen was a privately held company headquartered in Lakewood, CO and was a global developer of healthcare information software that empowers patients to make better decisions. Healthagen was co-founded by two practicing emergency physicians, Drs. Peter Hudson and Wayne Guerra, and the companys flagship Web and mobile product iTriage which allows medical searches and self-assessments. iTriage lets users check symptoms, find doctors, make appointments, and do medical shopping.In October 2011, Healthagen and its iTriage app was purchased by Aetna. iTriage's valuation / acquisition price and other terms of the acquisition were not disclosed. Per Aetna, iTriage will be augmented with new features and become part of Aetnas accountable care organization.

Healthagen Headquarter Location

12265 W Bayaud Ave

Lakewood, Colorado, 80228,

United States

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Healthagen Patents

Healthagen has filed 1 patent.

patents chart

Application Date

Grant Date

Title

Related Topics

Status

12/10/2013

8/4/2020

Chromosomes (human), Data management, SQL data access, Computer networking, Business intelligence

Grant

Application Date

12/10/2013

Grant Date

8/4/2020

Title

Related Topics

Chromosomes (human), Data management, SQL data access, Computer networking, Business intelligence

Status

Grant

Latest Healthagen News

Van Crocker, Jr., MBA, Joins Cancer Treatment Centers of America's Newly Formed Oncology Data, Analytics & Research Business as President and Co-Founder

Apr 6, 2020

0 Message : *Required fields BOCA RATON, Fla., April 6, 2020 /PRNewswire/ -- Percy Van Crocker, Jr., MBA, an entrepreneur who has spent his 20+ year career driving innovation and change in healthcare and technology, recently joined Cancer Treatment Centers of America's® (CTCA) Oncology Data, Analytics & Research Business as President and Co-Founder. In this role, Crocker will lead a team focused on harnessing genomic and clinical data to achieve a deep understanding of the patient journey and unlocking insights to identify value and improve outcomes. "At Cancer Treatment Centers of America, we're committed to ensuring the best possible results for our patients, and on a larger scale, shape a better future for cancer patients everywhere," said Pat Basu, MD, MBA , President and CEO of CTCA®. "Van is a highly qualified and experienced healthcare business leader with a proven track record in the data and analytics space. I'm thrilled to have him on board to lead the charge for our newly formed Oncology Data, Analytics & Research Business, which is not just about datasets, but the continued connection to patient and physician interactions." "In over two decades working in healthcare and technology, I've seen the impact cancer has on our communities across the country and believe in the power and potential of high-quality health data in unearthing new solutions. I'm excited to work hand in hand with the talented and passionate team at CTCA in our shared mission to establish robust, ongoing evidence for the overall improvement of cancer care," said Crocker. About Percy Van Crocker, Jr., MBA From 2013 to 2020, Crocker led Healthagen, a division of Aetna/CVS that enables highly impactful health research in payer environments. He transformed Healthagen from an idea into a fast-growing, profitable and well-known analytics business serving the pharmaceutical sector and others. Prior to Healthagen, Crocker led finance and business development for AuraSense, a biotechnology company founded by world-renowned nanotechnology authority, Dr. Chad Mirkin, and funded in part by AbbVie Biotech Ventures and Bill Gates. The company developed a broad array of nanoparticle-based genetic therapies and diagnostic platforms with applications in cancer and autoimmune conditions. AuraSense has thus far spawned the public company, Exicure. Prior to AuraSense, he was a management consultant with Booz & Company, focusing on strategic transactions and initiatives for payer/provider clients. He began his career with Oracle Corporation. Crocker holds an MBA (Honors) from Kellogg School of Management at Northwestern University in Illinois and a BS from the University of Virginia. About Cancer Treatment Centers of America Cancer Treatment Centers of America® (CTCA) is a national oncology network of hospitals and outpatient care centers offering an integrated approach that combines immunotherapy, surgery, radiation, chemotherapy, and advancements in precision medicine with supportive therapies to manage side effects and enhance quality of life during treatment and into survivorship. CTCA® publishes treatment results annually including patient experience, length of life, quality of life, patient safety and quality of care. CTCA also offers qualified patients a range of clinical trials that may reveal new treatment options supported by scientific and investigational research. CTCA patient satisfaction scores consistently rank among the highest for all cancer care providers in the country. Visit cancercenter.com for more information. Media Contact:

  • Where is Healthagen's headquarters?

    Healthagen's headquarters is located at 12265 W Bayaud Ave, Lakewood.

  • What is Healthagen's latest funding round?

    Healthagen's latest funding round is Acquired.

  • Who are the investors of Healthagen?

    Investors of Healthagen include Aetna.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.